This work was made possible in part by the NIH/NCI 1KM1CA156723 (NA), as well as grants from the National Institute of General Medical Sciences (8 P41 GM103545–14) from the National Institutes of Health through the Center for Integrative Biomedical Computing (CIBC).
Association of Atrial Fibrosis Quantified Using LGE-MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation
Article first published online: 11 JUL 2013
© 2013 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 24, Issue 10, pages 1104–1109, October 2013
How to Cite
Akoum, N., Fernandez, G., Wilson, B., Mcgann, C., Kholmovski, E. and Marrouche, N. (2013), Association of Atrial Fibrosis Quantified Using LGE-MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 24: 1104–1109. doi: 10.1111/jce.12199
BW reports participation on research grants supported by GE and Astellas. NM is cofounder and president of MARREK Inc, in which he holds stock options. Other authors: No disclosures.
- Issue published online: 8 OCT 2013
- Article first published online: 11 JUL 2013
- Accepted manuscript online: 10 JUN 2013 12:05PM EST
- Manuscript Accepted: 22 MAY 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 29 MAR 2013
- appendage thrombus;
- atrial fibrillation;
- catheter ablation;
- magnetic resonance imaging;
- transesophageal echocardiography
Atrial Fibrosis and Appendage Thrombus
Transesophageal echocardiography (TEE) is used to evaluate for left atrial appendage (LAA) thrombi prior to restoration of sinus rhythm in atrial fibrillation (AF). We examined the relationship of atrial fibrosis quantified using late gadolinium enhancement MRI (LGE-MRI) with TEE findings.
Methods and Results
We included 178 patients with AF, undergoing TEE and LGE-MRI prior to ablation or cardioversion. LGE-MRI and subsequent image processing was used to quantify atrial fibrosis based on signal intensity analysis. The mean CHADS2 score was 1.24 ± 1.08 and CHA2DS2-VASc was 2.08 ± 1.33. The LAA was classified as normal, spontaneous echocardiographic contrast (SEC) present or thrombus present. LAA thrombus was found in 12 patients (6.7%) while SEC was identified in 19 patients (10.7%). Patients with thrombus had higher atrial fibrosis compared to patients without thrombus (26.9 ± 17.4% vs 16.7 ± 10.5%; P < 0.01). Atrial fibrosis was also higher in patients with SEC (23.3 ± 13.7%) compared to those without SEC (16.7 ± 10.8%; P = 0.01). Patients with high atrial fibrosis (>20%) were more likely to have a LAA thrombus (odds ratio 4.6; P = 0.02) and SEC (odds ratio 2.6; P = 0.06). Multivariate logistic regression showed high fibrosis (odds ratio 3.6; P < 0.01) and CHADS2 ≥2 (odds ratio 3.5; P < 0.01) were significant predictors of TEE abnormalities (LAA thrombus or SEC). The area under the curve for the model including high fibrosis, AF type and CHADS2 ≥2 or CHA2DS2-VASc ≥2 was 0.73 compared to 0.63 and 0.65 for CHADS2 and CHA2DS2-VASc alone.
Atrial fibrosis is independently associated with appendage thrombus and spontaneous contrast. It provides additional risk stratification not captured by clinical parameters.